Literature DB >> 2760785

Liposomal pulmonary drug delivery. I. In vivo disposition of atropine base in solution and liposomal form following endotracheal instillation to the rabbit lung.

D Meisner1, J Pringle, M Mezei.   

Abstract

The potential of liposomes as carriers for local pulmonary drug delivery was investigated in the rabbit. Atropine base, a model compound for lipophilic drugs, was encapsulated in neutral MLVs and sprayed at the bifurcation of the trachea. Drug concentrations determined in the lung indicated liposomal encapsulation provided higher drug concentrations within pulmonary tissue for a more prolonged period of time as compared to the solution form. Comparison of drug levels in plasma and appearance of drug in urine demonstrated more rapid systemic absorption and elimination of 'free' drug. Greater accessibility of drug in solution to the systemic circulation was reflected in higher atropine concentrations in all internal organs studied. Liposome encapsulation favourably altered the disposition of atropine base when locally administered to the rabbit lung.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2760785     DOI: 10.3109/02652048909019920

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  4 in total

1.  Liposomes for controlled delivery of drugs to the lung.

Authors:  K M Taylor; J M Newton
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

2.  Targeted gene delivery to alveolar macrophages via Fc receptor-mediated endocytosis.

Authors:  Y Rojanasakul; L Y Wang; C J Malanga; J K Ma; J Liaw
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

3.  Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa.

Authors:  A Omri; C Beaulac; M Bouhajib; S Montplaisir; M Sharkawi; J Lagacé
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

4.  A review of formulations and preclinical studies of inhaled rifampicin for its clinical translation.

Authors:  Prakash Khadka; Jack Dummer; Philip C Hill; Rajesh Katare; Shyamal C Das
Journal:  Drug Deliv Transl Res       Date:  2022-09-21       Impact factor: 5.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.